Moderna's mRNA Norovirus Vaccine Trials

Norovirus vaccines face significant hurdles, with virtually no success from past efforts from HilleVax and Vaxxart. But Moderna's mRNA-1403, now in Phase 3 trials, is based on the company's mRNA technology, which controlled the COVID pandemic. Will it work here? Keep a bucket handy, just in case.